Fecal Analyzer Market Size, Trends and Growth Analysis by 2027

In 2019, the fecal analyzer market was valued at approximately US$ 657.44 million and is anticipated to grow to US$ 842.48 million by 2027, reflecting a compound annual growth rate (CAGR) of 3.3% from 2020 to 2027.

The expansion of the fecal analyzer market can be primarily linked to the rising rates of colorectal cancer, the implementation of various screening initiatives, an increase in the aging population, and advancements in healthcare technology. Nevertheless, challenges associated with the analysis process and the handling of fecal analyzers pose obstacles to market growth.
 
As individuals age, the degeneration of bodily cells and tissues increases the likelihood of chronic illnesses. Older adults are particularly susceptible to gastrointestinal disorders, including Crohn's disease, colorectal cancer, and irritable bowel syndrome (IBS). This vulnerability is largely due to alterations in the composition and metabolic functions of the colonic microbiome that occur with aging. Fecal testing provides insights into the physiology of gut microbiota, which is crucial for developing effective treatments for IBS.

Following colorectal cancer, IBS ranks as one of the most frequently diagnosed conditions among the elderly. Approximately 10% to 20% of older adults globally exhibit symptoms of IBS. According to the United Nations (UN) Global Population Prospects for 2019, the global population is expected to increase by 2 billion over the next three decades, reaching 9.7 billion by 2050, up from 7.7 billion in 2019. The growing elderly demographic is likely to contribute to a higher incidence of IBS and other gastrointestinal disorders in the future, thereby driving the demand for fecal analyzers.

The fecal analyzer market is categorized by product type into fully automated and semi-automatic fecal analyzers. In 2019, the fully automated fecal analyzer segment commanded a significant portion of the market and is projected to experience a higher CAGR throughout the forecast period. The growth of this segment is attributed to the analyzers' ability to perform multiple functions simultaneously, including dilution, blending, extraction, and sample suction.

From the perspective of end users, the fecal analyzer market is divided into hospitals, clinics, and other facilities. The hospitals segment represented the largest market share in 2019 and is expected to achieve the highest CAGR during the forecast period.
Key secondary sources utilized in the preparation of this report include the Food and Drug Administration (FDA), the Brazilian Association of Intestinal Cancer Prevention, the Dubai Health Authority, and the World Health Organization (WHO).